节点文献

长期生存急性髓性白血病23例临床分析

Clinical Analysis Of 23 Long-Tern Survival Patients With Acute Myeloid Leukemia

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 严怀秀刘晓伟张彦芳

【Author】 YAN Huai-xiu,LIU Xiao-wei, ZHANG Yan-fang.(Department of Hematology,the third offiliated Hospital of inner Mongolia medical college,Baotou 014010,China)

【机构】 内蒙古医学院第三附属医院血液科

【摘要】 目的总结分析我院收治的生存五年以上急性髓性白血病23例(AML)患者的临床情况,并探讨其影响预后的多种相关因素。方法分析1990~2003年167例中长期生存5年以上23例AML患者的临床及实验室资料。结果23例生存5年以上者,M1 1例,M2 5例,M3 13例,M4 1例,M5 3例,达完全缓解时间较短,完全缓解后坚持强化,化疗时间为3~5年。结论白血病细胞类型、达初次缓解的疗程和时间、年龄、个体化治疗是影响急性白血病患者生存的重要原因。

【Abstract】 Objective To sum up the clinical characteristics and analyze prognosis factors in 5-year long-tern survivors with acute myeloid leukemia. Methods Analyze Clinical features and laboratory results of 23 patients entered 5-year long-tern survival Between1990 and 2003 of all 167 patients with acute myeloid leukemia.Results Of all the 23 patients,M1 1cases,M2 5cases,M3 13cases,M4 1cases,M5 3cases,all patients insisting in consolidating therapy after complete remission(CR),The total chemotherapy time were 3~5 years according to patient condition.Conclusion The leukemia subtype、the age、the time to complete remission(CR) and individual therapy were important factors which could influent the long survive time of acute leukemia patients.

【关键词】 髓性白血病急性长期生存
【Key words】 myeloidleukemiaacutelong-tern survival
  • 【文献出处】 疾病监测与控制 ,Journal of Diseases Monitor & Control , 编辑部邮箱 ,2010年03期
  • 【分类号】R733.71
  • 【被引频次】3
  • 【下载频次】64
节点文献中: